Kintsugi(US) | $6,000,000 | (May 31, 2024)
Valar Labs | $22,000,000 | (May 31, 2024)
Plural Energy | $2,330,000 | (May 31, 2024)
Certified by Founder
Lodge
PetDx
start up
United States
- San Diego
- 09/12/2021
- Series B
- $62,000,000
PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatic algorithms empowering veterinarians to provide superior care to canine patients.
- Industry Biotechnology Research
- Website https://petdx.com/
- LinkedIn https://www.linkedin.com/company/petdx/
Related People
Daniel S. GrosuFounder
United States -
San Diego, California,
Making the world a better place for pets... and their humans.
HoundDog.ai | $3,100,000 | (May 31, 2024)
Fortunafi | $9,500,000 | (May 31, 2024)
Faircado | $3,252,930 | (May 31, 2024)
Basalt Tech | $3,500,000 | (May 31, 2024)
FintechOS | $60,000,000 | (May 31, 2024)
Remark | $10,300,000 | (May 31, 2024)
Revive | $3,500,000 | (May 31, 2024)
Viable(UK) | $3,100,000 | (May 31, 2024)
Weave | $10,000,000 | (May 31, 2024)